Robert F. Apple, Executive Vice President & CFO at ANTARES PHARMA, INC. (ATRS), sold 115,000 shares at $4.01 ($462K) on 2013-06-03, disclosed to the SEC on 2013-06-05.
Scheduled sale ($462k) by Executive Vice President & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.01 | 86,400 | $346K | 75.0% |
| 2 | $4.03 | 28,600 | $115K | 25.0% |
| Total | $4.01 avg | 115,000 | $462K | 100% |
| Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |